Cargando…
Better late than never: eventual seroconversion against SARS-CoV-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Nephrology. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405446/ https://www.ncbi.nlm.nih.gov/pubmed/34478748 http://dx.doi.org/10.1016/j.kint.2021.08.018 |
_version_ | 1783746337722859520 |
---|---|
author | De Greef, Julien Devresse, Arnaud Saad Albichr, Imane Scohy, Anais Kanaan, Nada Georgery, Hélène Belkhir, Leila Kabamba, Benoit Yombi, Jean Cyr Goffin, Eric |
author_facet | De Greef, Julien Devresse, Arnaud Saad Albichr, Imane Scohy, Anais Kanaan, Nada Georgery, Hélène Belkhir, Leila Kabamba, Benoit Yombi, Jean Cyr Goffin, Eric |
author_sort | De Greef, Julien |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8405446 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | International Society of Nephrology. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84054462021-08-31 Better late than never: eventual seroconversion against SARS-CoV-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy De Greef, Julien Devresse, Arnaud Saad Albichr, Imane Scohy, Anais Kanaan, Nada Georgery, Hélène Belkhir, Leila Kabamba, Benoit Yombi, Jean Cyr Goffin, Eric Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2021-11 2021-08-31 /pmc/articles/PMC8405446/ /pubmed/34478748 http://dx.doi.org/10.1016/j.kint.2021.08.018 Text en © 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor De Greef, Julien Devresse, Arnaud Saad Albichr, Imane Scohy, Anais Kanaan, Nada Georgery, Hélène Belkhir, Leila Kabamba, Benoit Yombi, Jean Cyr Goffin, Eric Better late than never: eventual seroconversion against SARS-CoV-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy |
title | Better late than never: eventual seroconversion against SARS-CoV-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy |
title_full | Better late than never: eventual seroconversion against SARS-CoV-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy |
title_fullStr | Better late than never: eventual seroconversion against SARS-CoV-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy |
title_full_unstemmed | Better late than never: eventual seroconversion against SARS-CoV-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy |
title_short | Better late than never: eventual seroconversion against SARS-CoV-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy |
title_sort | better late than never: eventual seroconversion against sars-cov-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405446/ https://www.ncbi.nlm.nih.gov/pubmed/34478748 http://dx.doi.org/10.1016/j.kint.2021.08.018 |
work_keys_str_mv | AT degreefjulien betterlatethannevereventualseroconversionagainstsarscov2inakidneytransplantrecipientafterrepeatedimmunechallengeandmonoclonalantibodytherapy AT devressearnaud betterlatethannevereventualseroconversionagainstsarscov2inakidneytransplantrecipientafterrepeatedimmunechallengeandmonoclonalantibodytherapy AT saadalbichrimane betterlatethannevereventualseroconversionagainstsarscov2inakidneytransplantrecipientafterrepeatedimmunechallengeandmonoclonalantibodytherapy AT scohyanais betterlatethannevereventualseroconversionagainstsarscov2inakidneytransplantrecipientafterrepeatedimmunechallengeandmonoclonalantibodytherapy AT kanaannada betterlatethannevereventualseroconversionagainstsarscov2inakidneytransplantrecipientafterrepeatedimmunechallengeandmonoclonalantibodytherapy AT georgeryhelene betterlatethannevereventualseroconversionagainstsarscov2inakidneytransplantrecipientafterrepeatedimmunechallengeandmonoclonalantibodytherapy AT belkhirleila betterlatethannevereventualseroconversionagainstsarscov2inakidneytransplantrecipientafterrepeatedimmunechallengeandmonoclonalantibodytherapy AT kabambabenoit betterlatethannevereventualseroconversionagainstsarscov2inakidneytransplantrecipientafterrepeatedimmunechallengeandmonoclonalantibodytherapy AT yombijeancyr betterlatethannevereventualseroconversionagainstsarscov2inakidneytransplantrecipientafterrepeatedimmunechallengeandmonoclonalantibodytherapy AT goffineric betterlatethannevereventualseroconversionagainstsarscov2inakidneytransplantrecipientafterrepeatedimmunechallengeandmonoclonalantibodytherapy |